China Propofol Market Survey Report 2021-2025 –


DUBLIN – (COMMERCIAL THREAD)–The “Chinese Propofol Market Investigation Report 2021-2025” the report was added to offer.

According to the market research, the sales of Propofol in the Chinese market increased year on year from 2016 to 2019. Due to the impact of the new corona epidemic on the overall diagnostic and treatment services medical sales declined from CNY 1.232 billion in 2019 to CNY 1.308 billion in 2020, down 14.28% year-on-year. The sales CAGR of Propofol in China from 2016 to 2020 is 1.89%.

Propofol is a short-acting intravenous anesthetic. Its uses include induction and maintenance of general anesthesia, sedation for mechanically ventilated adults, and procedural sedation. It is also used for status epilepticus if other medicines have not worked. Its product was developed by Fresenius Kabi Deutschland GmbH.

Propofol was approved for clinical use in China in 1994 and is currently included in China’s medical insurance. In the first half of 2021, there are 7 manufacturers in the Chinese propofol market, among which Fresenius Kabi Deutschland GmbH holds the largest market share.

The analyst expects sales of Propofol to experience restorative growth from 2021 to 2025 with the new corona outbreak actually mitigating. In addition, Propofol has a rapid onset, stable induction, and rapid and complete recovery. Based on these advantages, the sales volume of Propofol will increase steadily in the future.

In addition, Propofol is also used in veterinary clinical anesthesia. With the expansion of the Chinese pet market and the servitization and standardization of pet hygiene, Propofol will also expand into the pet medicine market, leading to its sales and volume growth. of sales.

Topics covered:

  • The impact of COVID-19 on the propofol market in China

  • 2016-2020 Chinese Propofol Sales Value

  • Competitive landscape of the Chinese propofol market

  • Propofol price in China

  • China Propofol Price by Regions and Manufacturers

  • Analysis of Factors Affecting the Development of the Chinese Propofol Market

  • Prospects of the Chinese propofol market from 2021 to 2025

Main topics covered:

1 Relevant concept of propofol

1.1 Indications for propofol

1.2 Development of Propofol in China

1.3 Government approval of propofol in China

1.4 The impact of COVID-19 on propofol sales in China

2 Propofol sales in China, 2016-2020

2.1 Propofol sales value

2.1.1 Overall value of sales

2.1.2 Sales value by region

2.2 Propofol sales volume

2.2.1 Global sales volume

2.2.2 Sales Volume by Region

2.3 China Propofol Sales by Dosage Form, 2016-2020

2.3.1 Injection

2.3.2 Analysis of another dosage form

3 Analysis of Major Manufacturers of Propofol in China in 2020

3.1 Major Manufacturers of Propofol Market Share Analysis

3.1.1 Market Share by Sales Value Survey

3.1.2 Market Share by Sales Volume Survey

3.2 Fresenius Kabi Deutschland GmbH

3.2.1 Company profile

3.2.2 Sales of PROPOFOL 1% FRESENIUS AND PROPOFOL 2% FRESENIUS (Fresenius Kabi Deutschland GmbH’s Propofol) in China

3.3 Aspen Pharma Trading Ltd

3.3.1 Company profile

3.3.2 Sales of DIPRIVAN (Aspen Pharma Trading Ltd’s propofol) in China

3.4 Sichuan Guorei Pharmaceutical Co., Ltd.

3.4.1 Company profile

3.4.2 Sales of Leweijing (propofol by Sichuan Guorei Pharmaceutical Co., Ltd.) in China

3.5 Guangdong Jiabo Pharmaceutical Co., Ltd.

3.5.1 Company Profile

3.5.2 Sales of Dishing (Guangdong Jiabo Pharmaceutical Co., Ltd.) propofol in China

3.6 Xian Libang Pharmaceutical Co., Ltd.

3.6.1 Company Profile

3.6.2 Sales of Limengxin (Propropofol by Xian Libang Pharmaceutical Co., Ltd.) in China

4 Propofol Price for Different Manufacturers in China, 2020-2021

4.1 Fresenius Kabi Deutschland GmbH (PROPOFOL 1% FRESENIUS AND PROPOFOL 2% FRESENIUS)

4.2 Aspen Pharma Trading Ltd (DIPRIVAN)

4.3 Sichuan Guorei Pharmaceutical Co., Ltd. (Leweijing)

4.4 Guangdong Jiabo Pharmaceutical Co., Ltd. (Dishining)

4.5 Xian Libang Pharmaceutical Co., Ltd. (Limengxin)

5 China Propofol Market Outlook, 2021-2025

5.1 Factors influencing the development of the Chinese propofol market

5.1.1 The impact of COVID-19 on the Chinese propofol market

5.1.2 Market Drivers and Opportunities

5.1.3 Market threats and challenges

5.2 Market Size Forecast

5.3 Market Trend Forecast

For more information on this report, visit


Comments are closed.